Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03635567 |
|---|---|
| Brief Title: | Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) |
| First Submitted : | August 15, 2018 |
| First Submitted that Met QC Criteria : | August 15, 2018 |
| First Posted : | August 17, 2018 |
| Results First Submitted : | September 20, 2023 |
| Results First Submitted that Met QC Criteria : | September 20, 2023 |
| Results First Posted : | October 12, 2023 |
| Last Update Submitted that Met QC Criteria : | January 12, 2024 |
| Last Update Posted : | January 17, 2024 |